AR013490A1 - Composicion antimicrobiana. - Google Patents

Composicion antimicrobiana.

Info

Publication number
AR013490A1
AR013490A1 ARP980104571A ARP980104571A AR013490A1 AR 013490 A1 AR013490 A1 AR 013490A1 AR P980104571 A ARP980104571 A AR P980104571A AR P980104571 A ARP980104571 A AR P980104571A AR 013490 A1 AR013490 A1 AR 013490A1
Authority
AR
Argentina
Prior art keywords
combination
antimicrobial composition
compositions
eltratamietno
vinylpyrrolidinone
Prior art date
Application number
ARP980104571A
Other languages
English (en)
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of AR013490A1 publication Critical patent/AR013490A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invencion se refiere a composiciones antimicrobianas que comprenden una combinacion de derivados de vinilpirrolidinona cefalosporina de formula generalI con antibioticos de carbapénem o con inhibidores de la beta-lactamasa, para emplear encomp osiciones para la elaboracion de un medicamento para eltratamietno y profilaxis de enfermedades infecciosas, incluídas las infecciones por MRSA, y para composiciones farmacéuticas que contienen la combinacion.
ARP980104571A 1997-09-15 1998-09-14 Composicion antimicrobiana. AR013490A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115997 1997-09-15

Publications (1)

Publication Number Publication Date
AR013490A1 true AR013490A1 (es) 2000-12-27

Family

ID=8227350

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104571A AR013490A1 (es) 1997-09-15 1998-09-14 Composicion antimicrobiana.

Country Status (16)

Country Link
US (1) US6150350A (es)
EP (1) EP0911030B1 (es)
JP (1) JP4621311B2 (es)
KR (1) KR100630012B1 (es)
CN (1) CN1186021C (es)
AR (1) AR013490A1 (es)
AT (1) ATE292994T1 (es)
AU (1) AU747285B2 (es)
BR (1) BR9803443A (es)
CA (1) CA2247232C (es)
DE (1) DE69829720T2 (es)
DK (1) DK0911030T3 (es)
ES (1) ES2241084T3 (es)
PT (1) PT911030E (es)
TR (1) TR199801835A3 (es)
ZA (1) ZA988399B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID28433A (id) * 1998-06-22 2001-05-24 Hoffmann La Roche Turunan propenil sefalosporin
AU1654900A (en) * 1998-12-03 2000-06-19 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
JP4583559B2 (ja) * 2000-07-24 2010-11-17 栄研化学株式会社 Ｍｒｓａスクリーニング用培地
CN100384857C (zh) * 2003-11-28 2008-04-30 浙江永宁制药厂 耐β-内酰胺酶的头孢菌素酯化合物及其盐
CN112608369A (zh) * 2020-12-30 2021-04-06 中国海洋大学 一种具有抑菌活性的细菌素及其生产方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384410B1 (en) * 1989-02-21 1995-05-17 Banyu Pharmaceutical Co., Ltd. Antimicrobial composition
JPH0347122A (ja) * 1989-02-21 1991-02-28 Banyu Pharmaceut Co Ltd 抗菌性組成物
GB9019743D0 (en) * 1990-09-10 1990-10-24 Beecham Group Plc Novel compounds
KR100214288B1 (ko) * 1993-04-16 1999-08-02 성재갑 안개서림 방지용 내마모성 피복조성물 및 이를 도포한 합성수지 성형품
DE69431691T2 (de) * 1993-04-16 2003-08-21 Basilea Pharmaceutica Ag Binni Cephalosporin-Derivate
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
US5925632A (en) * 1995-02-27 1999-07-20 Hoffmann-La Roche Inc. Derivatives of 3-pyrrolidylidene-2-one-cephalsporines
DK0841339T3 (da) * 1996-11-06 2007-07-02 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporinderivater

Also Published As

Publication number Publication date
TR199801835A2 (xx) 1999-04-21
CA2247232C (en) 2007-08-28
CA2247232A1 (en) 1999-03-15
DE69829720D1 (de) 2005-05-19
PT911030E (pt) 2005-08-31
ES2241084T3 (es) 2005-10-16
DE69829720T2 (de) 2006-03-09
JP4621311B2 (ja) 2011-01-26
ATE292994T1 (de) 2005-04-15
AU747285B2 (en) 2002-05-16
EP0911030A3 (en) 1999-10-13
EP0911030A2 (en) 1999-04-28
DK0911030T3 (da) 2005-08-01
ZA988399B (en) 1999-03-15
CN1186021C (zh) 2005-01-26
KR100630012B1 (ko) 2006-11-30
KR19990029769A (ko) 1999-04-26
BR9803443A (pt) 2000-02-08
JPH11140087A (ja) 1999-05-25
US6150350A (en) 2000-11-21
CN1216246A (zh) 1999-05-12
AU8425198A (en) 1999-04-01
TR199801835A3 (tr) 1999-04-21
EP0911030B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
NO20042271L (no) Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder
AU2001278003A1 (en) Bacteriophage having multiple host range
FI20012510A (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
BRPI0307267B8 (pt) uso de compostos inibidores de beta-lactamases e composições farmacêuticas para terapia antibacteriana
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
BRPI0213063B8 (pt) composto antibiótico de ação dupla, sua composição farmacêutica e seu uso
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
AR005597A1 (es) Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados.
PA8489501A1 (es) Antibioticos cetolidos
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
NZ530845A (en) Composition for topical administration
HN2002000332A (es) Sales de acido succinico de 5,7,14 triazatetraciclo (10. 3.1.02.11.04,9)-hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
AR013490A1 (es) Composicion antimicrobiana.
EP1142573A4 (en) ANTIBACTERIAL MEDICAL COMPILATION
PT1289998E (pt) Novo processo para a preparacao de derivados de vinil-pirrolidinona cefalosporina
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
PA7801701A1 (es) Compuestos ariltios
MXPA05010783A (es) Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
GT200200206A (es) 2-amino-6-(fenilo sustituido en las posiciones 2,4,5)-piridinas
SV2002000210A (es) Profarmacos de higromicina a ref. pc10548ajnm/bb

Legal Events

Date Code Title Description
FA Abandonment or withdrawal